{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:37:31Z","timestamp":1792874251567,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eprac.2026.08.027","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:19:09Z","timestamp":1790896749000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of the Clinical Profile of Multiple Endocrine Neoplasia Syndromes and the Association With Other Tumors"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-3344","authenticated-orcid":false,"given":"Clarissa C.","family":"Pedreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Olivar-Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhangi","family":"Tuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Blouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Udler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibha","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusmita","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 6","key":"10.1016\/j.eprac.2026.08.027_bib1","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/NAN.0000000000000143","article-title":"Multiple endocrine neoplasia syndromes","volume":"38","author":"Clark","year":"2015","journal-title":"J Infus Nurs"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.027_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.rcl.2015.12.001","article-title":"Multiple endocrine neoplasia syndromes: a comprehensive imaging review","volume":"54","author":"Grajo","year":"2016","journal-title":"Radiol Clin North Am"},{"issue":"8","key":"10.1016\/j.eprac.2026.08.027_bib3","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/imj.14394","article-title":"Multiple endocrine neoplasia: an update","volume":"49","author":"McDonnell","year":"2019","journal-title":"Intern Med J"},{"issue":"7","key":"10.1016\/j.eprac.2026.08.027_bib4","doi-asserted-by":"crossref","first-page":"e1482","DOI":"10.1210\/clinem\/dgae055","article-title":"Beyond MEN1, when to think about MEN4? Retrospective study on 5600 patients in the French population and literature review","volume":"109","author":"Chevalier","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.027_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical aspects of multiple endocrine neoplasia type 1","volume":"17","author":"Al-Salameh","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.027_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1406028","article-title":"Breast-cancer predisposition in multiple endocrine neoplasia type 1","volume":"371","author":"Dreijerink","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.eprac.2026.08.027_bib7","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1158\/0008-5472.CAN-05-4461","article-title":"Menin links estrogen receptor activation to histone H3K4 trimethylation","volume":"66","author":"Dreijerink","year":"2006","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.027_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.31662\/jmaj.2020-0021","article-title":"Roles of the RETProto-oncogene in cancer and development","volume":"3","author":"Takahashi","year":"2020","journal-title":"JMA J"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.027_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0092-8674(90)90659-3","article-title":"PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas","volume":"60","author":"Grieco","year":"1990","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.027_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/EP:13:1:03","article-title":"RET\/PTC rearrangement in thyroid tumors","volume":"13","author":"Nikiforov","year":"2002","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.027_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm.2658","article-title":"RET, ROS1 and ALK fusions in lung cancer","volume":"18","author":"Takeuchi","year":"2012","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.eprac.2026.08.027_bib12","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.027_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","article-title":"Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database","volume":"58","author":"Giusti","year":"2017","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.027_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2011.04227.x","article-title":"Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database","volume":"76","author":"Sakurai","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.027_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2265.2007.02934.x","article-title":"Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers","volume":"67","author":"Machens","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.027_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13023-018-0938-8","article-title":"Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients","volume":"13","author":"Marini","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.027_bib17","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1097\/SLA.0000000000001211","article-title":"Better survival but changing causes of death in patients with multiple endocrine neoplasia type 1","volume":"261","author":"Norton","year":"2015","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.027_bib18","first-page":"10","article-title":"Adrenal liposarcoma: a novel presentation of multiple endocrine neoplasia type 1","volume":"9","author":"Duro","year":"2022","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.eprac.2026.08.027_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1191040","article-title":"Cutaneous lesions and other non-endocrine manifestations of multiple endocrine neoplasia type 1 syndrome","volume":"14","author":"Pierotti","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.027_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.31662\/jmaj.2022-0187","article-title":"A novel missense MEN1 mutation in a sporadic case of multiple endocrine neoplasia type 1 complicated with papillary thyroid carcinoma","volume":"6","author":"Shibuya","year":"2023","journal-title":"JMA J"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.027_bib21","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.12998\/wjcc.v10.i3.1032","article-title":"Multiple endocrine neoplasia type 1 combined with thyroid neoplasm: a case report and review of literatures","volume":"10","author":"Xu","year":"2022","journal-title":"World J Clin Cases"},{"issue":"7","key":"10.1016\/j.eprac.2026.08.027_bib22","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/PAS.0b013e3181e2b726","article-title":"Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior","volume":"34","author":"Papotti","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.eprac.2026.08.027_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.anndiagpath.2008.04.002","article-title":"Myxoid adrenal cortical neoplasms","volume":"12","author":"Raparia","year":"2008","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.027_bib24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"issue":"18","key":"10.1016\/j.eprac.2026.08.027_bib25","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/MCB.01001-08","article-title":"The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation","volume":"29","author":"Dreijerink","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.eprac.2026.08.027_bib26","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41379-020-0574-4","article-title":"Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)","volume":"33","author":"Chu","year":"2020","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.eprac.2026.08.027_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288482","article-title":"Evaluating the role of MEN1 gene expression and its clinical significance in breast cancer patients","volume":"18","author":"Massey","year":"2023","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.eprac.2026.08.027_bib28","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.celrep.2017.02.025","article-title":"Enhancer-mediated oncogenic function of the Menin tumor suppressor in breast cancer","volume":"18","author":"Dreijerink","year":"2017","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.eprac.2026.08.027_bib29","article-title":"Combined inhibition of KAT6A\/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancer","volume":"6","author":"Olsen","year":"2025","journal-title":"Cell Rep Med"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.027_bib30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-5347(17)45120-2","article-title":"Hypernephroma associated with multiple endocrine neoplasia type I: a case report","volume":"136","author":"Denker","year":"1986","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.027_bib31","first-page":"103","article-title":"Syndrome de Wermer associ\u00e9 \u00e0 une tumeur r\u00e9nale bilat\u00e9rale [Wermer syndrome associated with a bilateral renal tumor]","volume":"6","author":"Jeddi","year":"1996","journal-title":"Prog Urol"},{"issue":"8","key":"10.1016\/j.eprac.2026.08.027_bib32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1507\/endocrj.EJ14-0021","article-title":"Sarcomatoid carcinoma of the kidney in a MEN1 patient: case report and genetic profile","volume":"61","author":"Cavalli","year":"2014","journal-title":"Endocr J"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.027_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000440985","article-title":"A possible new multiple endocrine neoplasia mutation in a patient with a prototypic multiple endocrine neoplasia presentation","volume":"6","author":"Buzzola","year":"2016","journal-title":"Cardiorenal Med"},{"issue":"19","key":"10.1016\/j.eprac.2026.08.027_bib34","first-page":"6135","article-title":"Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.eprac.2026.08.027_bib35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tibs.2013.05.005","article-title":"Menin: a scaffold protein that controls gene expression and cell signaling","volume":"38","author":"Matkar","year":"2013","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.027_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41388-021-02039-2","article-title":"Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity","volume":"41","author":"Cherif","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.eprac.2026.08.027_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.591501","article-title":"Phenotypes associated with MEN1 syndrome: a focus on genotype-phenotype correlations","volume":"11","author":"Mele","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.027_bib38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/jc.2018-01170","article-title":"UMD-MEN1 database: an overview of the 370 MEN1 variants present in 1676 patients from the French population","volume":"104","author":"Romanet","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2026.08.027_bib39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/GIM.0b013e318216cc6d","article-title":"Multiple endocrine neoplasia type 2: an overview","volume":"13","author":"Moline","year":"2011","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.027_bib40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.eprac.2026.08.027_bib41","doi-asserted-by":"crossref","first-page":"944","DOI":"10.21037\/atm-21-1165","article-title":"A narrative review of multiple endocrine neoplasia syndromes: genetics, clinical features, imaging findings, and diagnosis","volume":"9","author":"Hu","year":"2021","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.027_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14310\/horm.2002.1218","article-title":"Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management","volume":"8","author":"Raue","year":"2009","journal-title":"Hormones (Athens)"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.027_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/thy.2016.0411","article-title":"Distribution of RET mutations in multiple endocrine neoplasia 2 in Denmark 1994-2014: a nationwide study","volume":"27","author":"Mathiesen","year":"2017","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.027_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-10-0333","article-title":"Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes","volume":"163","author":"Romei","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.027_bib45","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1038\/s41467-018-07341-4","article-title":"RET rearrangements are actionable alterations in breast cancer","volume":"9","author":"Paratala","year":"2018","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.eprac.2026.08.027_bib46","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.jtho.2018.06.021","article-title":"Emergence of a RET V804M gatekeeper mutation during treatment with vandetanib in RET-Rearranged NSCLC","volume":"13","author":"Dagogo-Jack","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1016\/j.eprac.2026.08.027_bib47","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1158\/1078-0432.CCR-16-1679","article-title":"RET aberrations in diverse cancers: next-Generation sequencing of 4,871 patients","volume":"23","author":"Kato","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eprac.2026.08.027_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101911","article-title":"RET fusions in solid tumors","volume":"81","author":"Li","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.eprac.2026.08.027_bib49","article-title":"A comprehensive overview of the relationship between RET gene and tumor occurrence","volume":"13","author":"Zhao","year":"2023","journal-title":"Front Oncol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:56:49Z","timestamp":1792871809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26011602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"alternative-id":["S1530891X26011602"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.08.027","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the Clinical Profile of Multiple Endocrine Neoplasia Syndromes and the Association With Other Tumors","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}